E25Bio Inc. — Form D
E25Bio Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-22. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-22
- Form: D
- Accession: 0001786210-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $2.3M
- Investors: 7
- Date of first sale: 2019-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-347179
Issuer
- Name: E25Bio Inc.
- CIK: 0001786210
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 501 MASSACHUSETTS AVENUE, OFFICE 221, CAMBRIDGE, MA, 02139
- Phone: 857-277-9050
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jeff Takle | Director | Cambridge, MA |
| Jeff Takle | Executive Officer | Cambridge, MA |
| Ann DeWitt | Director | Woburn, MA |
| Bobby Herrara | Executive Officer | Cambridge, MA |
| Prashant Chouta | Director | Cambridge, MA |
| Prashant Chouta | Executive Officer | Cambridge, MA |
| Shadah Brooke Enrique | Executive Officer | Cambridge, MA |
| Irene Bosch | Director | Cambridge, MA |
| Irene Bosch | Executive Officer | Cambridge, MA |
| Bobby Brooke Herrera | Executive Officer | Cambridge, MA |
Other filings by this issuer (3)
More